Publication | Closed Access

High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients

High-intensity StatinsMedicinePharmacologyPd-1 InhibitorsImproved Clinical ActivityPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung Cancer